Cellex Incorporated Email Format
Medical Equipment ManufacturingNorth Carolina, United States11-50 Employees
Founded in 2002, Cellex Incorporated is a biotechnology company that develops technologies, instruments and assays for testing of human diseases and conditions, particularly at point-of-care (POC) settings. On April 1, 2020, Cellex was the first company to receive the Emergency Use Authorization (EUA) for the COVID-19 serology test by the FDA for the qSARS-CoV-2 IgG/IgM Rapid Test. The corporate headquarters are located in Research Triangle Park, North Carolina. Cellex has R&D staff and manufacturing facilities in China. Product Page - cellexcovid.com